Abstract

The UT-A1 urea transporter is crucial to the kidney's ability to generate concentrated urine. Native UT-A1 from kidney inner medulla (IM) is a heavily glycosylated protein with two glycosylation forms of 97 and 117 kDa. In diabetes, UT-A1 protein abundance, particularly the 117 kD isoform, is significantly increased corresponding to an increased urea permeability in perfused IM collecting ducts, which plays an important role in preventing the osmotic diuresis caused by glucosuria. However, how the glycan carbohydrate structure change and the glycan related enzymes regulate kidney urea transport activity, particularly under diabetic condition, is largely unknown. In this study, using sugar-specific binding lectins, we found that the carbohydrate structure of UT-A1 is changed with increased amounts of sialic acid, fucose, and increased glycan branching under diabetic conditions. These changes were accompanied by altered UT-A1 association with the galectin proteins, β-galactoside glycan binding proteins. To explore the molecular basis of the alterations of glycan structures, the highly sensitive next generation sequencing (NGS) technology, Illumina RNA-seq, was employed to analyze genes involved in the process of UT-A1 glycosylation using streptozotocin (STZ)—induced diabetic rat kidney. Differential gene expression analysis combining with quantitative PCR revealed that expression of a number of important glycosylation related genes were changed under diabetic conditions. These genes include the glycosyltransferase genes Mgat4a, the sialylation enzymes St3gal1 and St3gal4 and glycan binding protein galectin-3, -5, -8, and -9. In contrast, although highly expressed in kidney IM, the glycosyltransferase genes Mgat1, Mgat2, and fucosyltransferase Fut8, did not show any changes. Conclusions: In diabetes, not only is UT-A1 protein abundance increased but the protein's glycan structure is also significantly changed. UT-A1 protein becomes highly sialylated, fucosylated and branched. Consistently, a number of crucial glycosylation related genes are changed under diabetic conditions. The alteration of these genes may contribute to changes in the UT-A1 glycan structure and therefore modulate kidney urea transport activity and alleviate osmotic diuresis caused by glucosuria in diabetes.

Highlights

  • Urea is an important solute that contributes to the inner medullary osmolarity gradient in the kidney

  • The proportion of UT-A1 bound to sambucus nigra lectin (SNA), aurantia lectin (AAL), and phaseolus vulgaris leukoagglutinin (PHA-L) form in the STZ rat inner medulla (IM) is notably increased when compared to the proportion in the control rat IM

  • The increased UT-A1 binding to SNA, AAL, and PHA-L is not due to the protein overloading or extended exposure time since the UT-A1 bound to concanavalin A (Con A) and galanthus nivalis lectin (GNL)

Read more

Summary

Introduction

Urea is an important solute that contributes to the inner medullary osmolarity gradient in the kidney. The major mechanism for delivering urea to the inner medullary interstitium is urea reabsorption from the terminal inner medullary collecting duct (IMCD) mediated by the UT-A1 urea transporter This process is mainly controlled by vasopressin in vivo. A functional study using tubule perfusion showed that the increased 117 kDa glycoform in the IM is associated with increased urea transport activity (Pech et al, 2005) This suggests that changes in the relative abundance of the 97 and 117 kDa forms of UT-A1 may have important regulatory roles for UTA1 function. Mutation of this protein revealed that N-linked glycosylation plays an important role in UT-A1 trafficking, protein stability and bioactivity (Chen et al, 2006). The underlying mechanism by which glycosylation affects these processes remains largely undetermined

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call